Public perception of risk-reducing salpingectomy for preventing ovarian cancer
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objective The fallopian tube is considered as the site of origin of serous ovarian cancer, and risk-reducing salpingectomy (RRS) has been proposed as a new and safe strategy for preventing ovarian cancer. However, little is known about the public perception of RRS. Methods We performed a questionnaire survey of 100 healthy female volunteers in November 2014. Questionnaire for this survey included questions on demographics, medical history, knowledge of and belief about RRS, and barrier to its application. Results Among 100 respondents, 71% did not realize the seriousness of ovarian cancer, 79% were unaware of the fact that salpinx was the origin of ovarian cancer, and 87% stated that they had never heard of RRS as a preventive method for ovarian cancer. Also, 98% of respondents replied that they had the right to be informed about RRS and the choice given. The respondents’ fears about RRS included increased risk of surgical complications (68%), no benefit (8%), and increased surgical costs (3%). Conclusion Most general women were unaware of RRS as a method for preventing ovarian cancer in women at average risk. Therefore, physicians should discuss RRS with patients and consider this procedure at the time of abdominal or pelvic surgery.
Abstract
Objective The fallopian tube is considered as the site of origin of serous ovarian cancer, and risk-reducing salpingectomy (RRS) has been proposed as a new and safe strategy for preventing ovarian cancer. However, little is known about the public perception of RRS. Methods We performed a questionnaire survey of 100 healthy female volunteers in November 2014. Questionnaire for this survey included questions on demographics, medical history, knowledge of and belief about RRS, and barrier to its application. Results Among 100 respondents, 71% did not realize the seriousness of ovarian cancer, 79% were unaware of the fact that salpinx was the origin of ovarian cancer, and 87% stated that they had never heard of RRS as a preventive method for ovarian cancer. Also, 98% of respondents replied that they had the right to be informed about RRS and the choice given. The respondents’ fears about RRS included increased risk of surgical complications (68%), no benefit (8%), and increased surgical costs (3%). Conclusion Most general women were unaware of RRS as a method for preventing ovarian cancer in women at average risk. Therefore, physicians should discuss RRS with patients and consider this procedure at the time of abdominal or pelvic surgery.
참고문헌 (21)
- 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2011", Cancer Research and Treatment, 46(2), pp.109~123 (2014), 대한암학회
- 윤정혜, "상피성 난소암 환자의 예후 인자 분석", Obstetrics & Gynecology Science, 49(3), pp.566~571 (2006), 대한산부인과학회
- Goff BA., "Ovarian carcinoma diagnosis", Cancer, 89, pp.2068~2075 (2000)
- Lurie G., "Symptom presentation in invasive ovarian carcinoma by tumor histological type and grade in a multiethnic population : a case analysis", Gynecol Oncol, 119, pp.278~284 (2010)
- Friedlander ML., "Prognostic factors in ovarian cancer", Semin Oncol, 25, pp.305~314 (1998)
- Rodriguez-Ayala G., "Ovarian cancer screening practices of obstetricians and gynecologists in puerto rico", Biomed Res Int, 2014, pp.920915~ (2014)
- Buys SS., "Effect of screening on ovarian cancer mortality : the Prostate, Lung, Colorectal and Ovarian(PLCO)Cancer Screening Randomized Controlled Trial", JAMA, 305, pp.2295~2303 (2011)
- Jayson GC., "Ovarian cancer", Lancet, 384, pp.1376~1388 (2014)
- Landen CN Jr., "Early events in the pathogenesis of epithelial ovarian cancer", J Clin Oncol, 26, pp.995~1005 (2008)
- Rosenblatt KA., "Lactation and the risk of epithelial ovarian cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives", Int J Epidemiol, 22, pp.192~197 (1993)
- Casagrande JT., ""Incessant ovulation"and ovarian cancer", Lancet, 2, pp.170~173 (1979)
- Cramer DW., "Factors affecting the association of oral contraceptives and ovarian cancer", N Engl J Med, 307, pp.1047~1051 (1982)
- Dubeau L., "The cell of origin of ovarian epithelial tumours", Lancet Oncol, 9, pp.1191~1197 (2008)
- Erickson BK., "The role of the fallopian tube in the origin of ovarian cancer", Am J Obstet Gynecol, 209, pp.409~414 (2013)
- Selvaggi SM., "Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament", Arch Pathol Lab Med, 124, pp.477~ (2000)
- Chan A., "New insights into the pathogenesis of ovarian carcinoma : time to rethink ovarian cancer screening", Obstet Gynecol, 120, pp.935~940 (2012)
- Salvador S., "The fallopian tube : primary site of most pelvic high-grade serous carcinomas", Int J Gynecol Cancer, 19, pp.58~64 (2009)
- "Salpingectomy associated with reduced ovarian cancer risk" (2014)[URL]
- "SGO clinical practice statement: salpingectomy for ovarian cancer prevention" (2013)[URL]
- Skytte AB., "Risk-reducing mastectomy and salpingo-oophorectomy in unaffected BRCA mutation carriers : uptake and timing", Clin Genet, 77, pp.342~349 (2010)
- Metcalfe KA., "International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers", Int J Cancer, 122, pp.2017~2022 (2008)